A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal ...
Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...
A top congressional Republican on Sunday criticized President Barack Obama's expected decision to reverse the Bush administration's limits on embryonic stem-cell research, calling it a distraction ...
The discovery of a gene essential to early embryonic development sheds light on the preliminary stages of human placenta formation. A team led by scientists from the University of California San Diego ...
The global stem cell therapy market is projected to experience robust growth, with an expected annual growth rate of 20% by 2029. Key drivers behind this expansion include a favorable investment ...
January 27, 2009 — Geron Corp announced it has received US Food and Drug Administration (FDA) approval for a phase 1 trial of GRNOPC1, a cell therapy derived from human embryonic stem cells (hESC), in ...
Tucked away in Room 112A of the Biomedical Center, a select group of students can be found spending hours each week cultivating human stem cells. The 15 students taking BIOL 0610: “Modeling Human ...
The International Society for Stem Cell Research (ISSCR) is pleased to announce that Alexander Meissner, Director at the Max Planck Institute for Molecular Genetics, Germany, has been named the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results